KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

PROXEN 500 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

500 MG

 

GENERIC NAME:

NAPROXEN

 

MANUFACTURER:

GRUNENTHAL

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

B

 

INDICATIONS:

Ankylosing spondylitis

Arthritis, gouty

Arthritis, juvenile

Arthritis, osteoarthritis

Arthritis, rheumatoid

Bursitis

Dysmenorrhea

Pain, mild to moderate

Tendonitis

 

SIDE EFFECTS:

abdominal pain

anaphylactic shock

anaphylactoid reactions

anemia

angioedema

aplastic anemia

aseptic meningitis

bleeding

blurred vision

confusion

constipation

depression

diaphoresis

diarrhea

dizziness

drowsiness

dyspepsia

dysphagia

dyspnea

edema

elevated hepatic enzymes

eosinophilia

erythema multiforme

esophageal stricture

esophageal ulceration

esophagitis

fatigue

gastritis

GI bleeding

GI perforation

glomerulonephritis

headache

hearing loss

heart failure

hematemesis

hematuria

hemolytic anemia

hepatic failure

hepatitis

hyperkalemia

hypertension

insomnia

interstitial nephritis

jaundice

leukopenia

malaise

melena

myasthenia

nausea/vomiting

nephrotic syndrome

neutropenia

odynophagia

pancreatitis

peptic ulcer

peripheral edema

photophobia

photosensitivity

platelet dysfunction

pneumonitis

pruritus

pseudoporphyria

purpura

pyrosis (heartburn)

rash (unspecified)

renal failure (unspecified)

renal papillary necrosis

Stevens-Johnson syndrome

stomatitis

thrombocytopenia

tinnitus

toxic epidermal necrolysis

urticaria

vasculitis

vertigo

visual impairment

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

acute bronchospasm

alcoholism

anemia

anticoagulant therapy

asthma

bone marrow suppression

breast-feeding

chemotherapy

children

coagulopathy

corticosteroid therapy

dehydration

dental disease

dental work

diabetes mellitus

edema

elderly

GI bleeding

GI disease

heart failure

hematological disease

hemophilia

hepatic disease

hypertension

hypovolemia

immunosuppression

intramuscular injections

jaundice

labor

nasal polyps

neutropenia

peptic ulcer disease

pregnancy

renal disease

renal failure

renal impairment

rheumatoid arthritis

surgery

systemic lupus erythematosus (SLE)

thrombocytopenia

tobacco smoking

ulcerative colitis

 

ADULT DOSE:

Antirheumatic (nonsteroidal anti-inflammatory) -Oral, 275 or 550 mg two times a day, morning and evening; or 275 mg in the morning and 550 mg in the evening. Note: During long-term administration, dosage may be adjusted according to patient response; lower doses may suffice. If necessary, dosage may be increased to up to 1650 mg per day for short periods. The use of this higher dose requires that the clinical benefit be increased sufficiently to offset the potential increased risk. Anti-inflammatory (nonsteroidal) or Analgesic (mild to moderate pain)-Oral, 550 mg initially, then 275 mg every six to eight hours as needed. Antigout agent -Oral, 825 mg initially, then 275 mg every eight hours until the attack has subsided. Antidysmenorrheal-Oral, 550 mg initially, then 275 mg every six to eight hours as needed. Note: For patient self-medication (over-the-counter use) for pain, fever, or dysmenorrhea-Patients 12 years of age and older: Oral, 220 mg every eight to twelve hours while symptoms persist, or Oral, 440 mg for the first dose only, followed by 220 mg twelve hours later and every eight to twelve hours thereafter as needed.

 

MAXIMUM ADULT DOSE:

For mild to moderate pain and dysmenorrhea-Up to a total dose of 1375 mg daily. Note: For patient self-medication (over-the-counter use) for pain, fever, or dysmenorrhea-Not to exceed 2 tablets (220 mg each) in twenty-four hours for patients 65 years of age or older or 3 tablets in twenty-four hours for patients 12 to 65 years of age.

 

PEDIATRIC DOSE:

Pediatric strength not available. It is recommended that naproxen oral suspension or tablets be administered instead.  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT